Loureiro J, Raimundo L, Calheiros J, Carvalho C, Barcherini V, Lima N, et al. Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance. Cancers (Basel). 2021;13: pubmed publisher

Lafita Navarro M, Kim M, Borenstein Auerbach N, Venkateswaran N, Hao Y, Ray R, et al. The aryl hydrocarbon receptor regulates nucleolar activity and protein synthesis in MYC-expressing cells. Genes Dev. 2018;32:1303-1308 pubmed publisher

Proietti S, Catizone A, Masiello M, Dinicola S, Fabrizi G, Minini M, et al. Increase in motility and invasiveness of MCF7 cancer cells induced by nicotine is abolished by melatonin through inhibition of ERK phosphorylation. J Pineal Res. 2018;64:e12467 pubmed publisher

Wu Q, Yan H, Tao S, Wang X, Mou L, Chen P, et al. XIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p. Oncotarget. 2017;8:16784-16800 pubmed publisher

Poli G, Ceni E, Armignacco R, Ercolino T, Canu L, Baroni G, et al. 2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma. Oncotarget. 2015;6:5695-706 pubmed

Acharya S, Yao J, Li P, Zhang C, Lowery F, Zhang Q, et al. Sphingosine-kinase-1 signaling promotes metastasis of triple-negative breast cancer. Cancer Res. 2019;: pubmed publisher

Garzón B, Gayarre J, Gharbi S, Díez Dacal B, Sánchez Gómez F, Timms J, et al. A biotinylated analog of the anti-proliferative prostaglandin A1 allows assessment of PPAR-independent effects and identification of novel cellular targets for covalent modification. Chem Biol Interact. 2010;183:212-21 pubmed publisher